Traws Pharma, Inc. Increase (Decrease) in Receivables
Traws Pharma, Inc. (TRAW) reported Increase (Decrease) in Receivables of -$340.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInReceivables · last filed 2026-08-14
- Traws Pharma, Inc. increase (decrease) in receivables for the quarter ending 2026-06-30 was $1.77M.
- Traws Pharma, Inc. increase (decrease) in receivables for the quarter ending 2026-03-31 was -$2.11M.
- Traws Pharma, Inc. increase (decrease) in receivables for the quarter ending 2025-12-31 was $1.80M.
- Traws Pharma, Inc. increase (decrease) in receivables for the quarter ending 2025-09-30 was $668.00K.
- Traws Pharma, Inc. increase (decrease) in receivables for fiscal 2025 was $2.03M, a 16.14% increase from fiscal 2024.
- Traws Pharma, Inc. increase (decrease) in receivables for fiscal 2024 was $1.75M.
- Traws Pharma, Inc. increase (decrease) in receivables for fiscal 2023 was -$11.00K, a 1200.00% decline from fiscal 2022.
- Traws Pharma, Inc. increase (decrease) in receivables for fiscal 2022 was $1.00K.
| Period end | Increase (Decrease) in Receivables 3 month | Increase (Decrease) in Receivables 6 month | Increase (Decrease) in Receivables 9 month | Increase (Decrease) in Receivables 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.77M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$340.00K 10-Q · filed 2026-08-14 | $1.46M derived: sum of 3 quarters · filed 2026-08-14 | $2.13M derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | -$2.11M 10-Q · filed 2026-05-15 | -$304.00K derived: sum of 2 quarters · filed 2026-05-15 | $364.00K derived: sum of 3 quarters · filed 2026-05-15 | $33.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | $1.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | $2.47M derived: sum of 2 quarters · filed 2026-04-15 | $2.14M derived: sum of 3 quarters · filed 2026-08-14 | $2.03M 10-K · filed 2026-04-15 |
| 2025-09-30 | $668.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $337.00K derived: sum of 2 quarters · filed 2026-08-14 | $226.00K 10-Q · filed 2025-11-13 | -$130.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | -$331.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$442.00K 10-Q · filed 2026-08-14 | -$798.00K derived: sum of 3 quarters · filed 2026-08-14 | |
| 2025-03-31 | -$111.00K 10-Q · filed 2026-05-15 | -$467.00K derived: sum of 2 quarters · filed 2026-05-15 | ||
| 2024-12-31 | -$356.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | $1.75M 10-K · filed 2026-04-15 | ||
| 2024-09-30 | $2.10M 10-Q · filed 2025-11-13 | |||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $1.00K derived: sum of 2 quarters · filed 2025-03-31 | $1.00K derived: sum of 3 quarters · filed 2025-03-31 | -$11.00K 10-K · filed 2025-03-31 |
| 2023-09-30 | $1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $1.00K derived: sum of 2 quarters · filed 2024-11-14 | -$11.00K 10-Q · filed 2024-11-14 | |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-15 | -$12.00K 10-Q · filed 2024-08-15 | ||
| 2023-03-31 | -$12.00K 10-Q · filed 2024-05-15 | |||
| 2022-12-31 | $1.00K 10-K · filed 2024-04-01 | |||
| 2022-03-31 | -$1.00K 10-Q · filed 2023-05-15 | -$2.00K derived: sum of 2 quarters · filed 2023-05-15 | $0.00 derived: sum of 3 quarters · filed 2023-05-15 | -$11.00K derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | -$1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $1.00K derived: sum of 2 quarters · filed 2023-03-30 | -$10.00K derived: sum of 3 quarters · filed 2023-03-30 | -$9.00K 10-K · filed 2023-03-30 |
| 2021-09-30 | $2.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$9.00K derived: sum of 2 quarters · filed 2022-11-14 | -$8.00K 10-Q · filed 2022-11-14 | -$17.00K derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | -$11.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | -$10.00K 10-Q · filed 2022-08-15 | -$19.00K derived: sum of 3 quarters · filed 2022-08-15 | -$14.00K derived: sum of 4 quarters · filed 2022-08-15 |
| 2021-03-31 | $1.00K 10-Q · filed 2022-05-13 | -$8.00K derived: sum of 2 quarters · filed 2022-05-13 | -$3.00K derived: sum of 3 quarters · filed 2022-05-13 | -$7.00K derived: sum of 4 quarters · filed 2022-05-13 |
| 2020-12-31 | -$9.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-21 | -$4.00K derived: sum of 2 quarters · filed 2022-03-21 | -$8.00K derived: sum of 3 quarters · filed 2022-03-21 | -$61.00K 10-K · filed 2022-03-21 |
| 2020-09-30 | $5.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $1.00K derived: sum of 2 quarters · filed 2021-11-15 | -$52.00K 10-Q · filed 2021-11-15 | $23.00K derived: sum of 4 quarters · filed 2021-11-15 |
| 2020-06-30 | -$4.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | -$57.00K 10-Q · filed 2021-08-16 | $18.00K derived: sum of 3 quarters · filed 2021-08-16 | -$1.67M derived: sum of 4 quarters · filed 2021-08-16 |
| 2020-03-31 | -$53.00K 10-Q · filed 2021-05-17 | $22.00K derived: sum of 2 quarters · filed 2021-05-17 | -$1.67M derived: sum of 3 quarters · filed 2021-05-17 | |
| 2019-12-31 | $75.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18 | -$1.62M derived: sum of 2 quarters · filed 2021-03-18 | $63.00K 10-K · filed 2021-03-18 | |
| 2019-09-30 | -$1.69M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | -$12.00K 10-Q · filed 2020-11-16 | ||
| 2019-06-30 | $1.68M 10-Q · filed 2020-08-12 | |||
| 2018-12-31 | $11.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-27 | -$37.00K derived: sum of 2 quarters · filed 2020-03-27 | -$442.00K derived: sum of 3 quarters · filed 2020-03-27 | -$24.00K 10-K · filed 2020-03-27 |
| 2018-09-30 | -$48.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | -$453.00K derived: sum of 2 quarters · filed 2019-11-12 | -$35.00K 10-Q · filed 2019-11-12 | -$33.00K derived: sum of 4 quarters · filed 2019-11-12 |
| 2018-06-30 | -$405.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | $13.00K 10-Q · filed 2019-08-14 | $15.00K derived: sum of 3 quarters · filed 2019-08-14 | -$161.00K derived: sum of 4 quarters · filed 2019-08-14 |
| 2018-03-31 | $418.00K 10-Q · filed 2019-05-15 | $420.00K derived: sum of 2 quarters · filed 2019-05-15 | $244.00K derived: sum of 3 quarters · filed 2019-05-15 | $351.00K derived: sum of 4 quarters · filed 2019-05-15 |
| 2017-12-31 | $2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | -$174.00K derived: sum of 2 quarters · filed 2019-04-01 | -$67.00K derived: sum of 3 quarters · filed 2019-04-01 | $28.00K 10-K · filed 2019-04-01 |
| 2017-09-30 | -$176.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | -$69.00K derived: sum of 2 quarters · filed 2018-11-14 | $26.00K 10-Q · filed 2018-11-14 | -$847.00K derived: sum of 4 quarters · filed 2018-11-14 |
| 2017-06-30 | $107.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14 | $202.00K 10-Q · filed 2018-08-14 | -$671.00K derived: sum of 3 quarters · filed 2018-08-14 | -$1.91M derived: sum of 4 quarters · filed 2018-08-14 |
| 2017-03-31 | $95.00K 10-Q · filed 2018-05-15 | -$778.00K derived: sum of 2 quarters · filed 2018-05-15 | -$2.02M derived: sum of 3 quarters · filed 2018-05-15 | -$1.24M derived: sum of 4 quarters · filed 2018-05-15 |
| 2016-12-31 | -$873.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | -$2.12M derived: sum of 2 quarters · filed 2018-03-16 | -$1.34M derived: sum of 3 quarters · filed 2018-03-16 | -$1.47M 10-K · filed 2018-03-16 |
| 2016-09-30 | -$1.24M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | -$464.00K derived: sum of 2 quarters · filed 2017-11-09 | -$600.00K 10-Q · filed 2017-11-09 | -$631.00K derived: sum of 4 quarters · filed 2017-11-09 |
| 2016-06-30 | $779.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | $643.00K 10-Q · filed 2017-08-14 | $612.00K derived: sum of 3 quarters · filed 2017-08-14 | $1.88M derived: sum of 4 quarters · filed 2017-08-14 |
| 2016-03-31 | -$136.00K 10-Q · filed 2017-05-15 | -$167.00K derived: sum of 2 quarters · filed 2017-05-15 | $1.10M derived: sum of 3 quarters · filed 2017-05-15 | $1.33M derived: sum of 4 quarters · filed 2017-05-15 |
| 2015-12-31 | -$31.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-29 | $1.24M derived: sum of 2 quarters · filed 2017-03-29 | $1.47M derived: sum of 3 quarters · filed 2017-03-29 | $1.37M 10-K · filed 2017-03-29 |
| 2015-09-30 | $1.27M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | $1.50M derived: sum of 2 quarters · filed 2016-11-14 | $1.40M 10-Q · filed 2016-11-14 | $1.52M derived: sum of 4 quarters · filed 2016-11-14 |
| 2015-06-30 | $233.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15 | $135.00K 10-Q · filed 2016-08-15 | $255.00K derived: sum of 3 quarters · filed 2016-08-15 | |
| 2015-03-31 | -$98.00K 10-Q · filed 2016-05-11 | $22.00K derived: sum of 2 quarters · filed 2016-05-11 | ||
| 2014-12-31 | $120.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-28 | $31.00K 10-K · filed 2016-03-28 | ||
| 2014-09-30 | -$89.00K 10-Q · filed 2015-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |